Drawing for GENESIS HEALTH ALLIANCE

USPTO serial 75182569

GENESIS HEALTH ALLIANCE

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
SMITH, CHAD
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GENESIS HEALTH ALLIANCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

GARY K PRICE

GARY K PRICE JOHNSON CARROLL & GRIFFITH PCP O BOX 6016EVANSVILLE, IN 47719-0016UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
200indicating membership in an association of health care providersABANDONEDMar 1, 1996

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 11, 1999ABN1ABANDONMENT - EXPRESS MAILED—
Feb 11, 1999DOCKASSIGNED TO EXAMINER—
Jan 11, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 13, 1998CNSLLETTER OF SUSPENSION MAILED—
Oct 8, 1998ZZZYPREVIOUS ACTION COUNT WITHDRAWN—
Mar 10, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 1997DOCKASSIGNED TO EXAMINER—
Apr 18, 1997DOCKASSIGNED TO EXAMINER—
Apr 14, 1997DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance